Heme Onc Flashcards
ALL (acute lymphoblastic leukemia)
common in kids
associated w/ Down syndrome
TdT+ (marker of pre-T and pre-B cells), CD10+
most resposive to therapy, may spread to CNS and testes
t(12;21) = better prognosis
B-ALL and T-ALL:
T-ALL (15-17%) associated w/ mediastinal mass (presents as SVC-like syndrome; may compress esophagus, trachea –> dysphagia, dyspnea, stridor). B-ALL (70-80%) p/w fever, malaise, bleeding, HSM
Chronic lymphocytic leukemia/small lymphocytic lymphoma
Elderly, most common adult leukemia CD20/23/5+ B cell neoplasm Slow progression, often asymp. Smudge cells ("Crushed Little Lymphocytes") Richter transformation into DLBCL
Hairy cell leukemia
Old men, TRAP+ (“it’s a trap!”)
Fuzzy on LM
Marrow fibrosis (dry tap on aspiration), massive splenomegaly, pancytopenia
AML (acute myelogenous leukemia) and APML (acute promyelocytic leukemia)
Older people 65 yo
Auer rods pathognom, (myelo)peroxidase+
Increased myeloblasts on periph smear
Risks: prior alkylating chemo, XRT, myeloproliferative disorders, Down syndrome
APML: t(15;17) forming PML/RARa fusion product that codes for abnormal retinoic acid receptor. Responds to all-trans retinoic acid (vit A), inducing diff’ation of promyelocytes; abundant Auer rods; DIC common
CML
Peak 45-85 yo, median 64 yo
Philly chromosome (t(9;22), BCR-ABL)
Dysregulated granulocyte prodxn, splenomegaly
Can transform into AML or ALL (blast crisis)
LAP is low (vs. leukemoid rxn)
Tx w/ tyr kinase inhibitors like imatinib
Factor V Leiden deficiency
Inherited mutation to factor V that makes it resistant to degradation by protein C –> most common cause of inherited hypercoagulability in Caucasians. Increased risk of thrombotic events (DVT/PE, cerebral vein thromboses, recurrent pregnancy loss)
Protein C or S deficiency
Inability to inactivate factors 5 and 8
Protein C deficiency –> increased risk of warfarin skin necrosis (because warfarin inactivates vit K dependent factors 2, 7, 9, 10, C, S - and C is first to fall with initiation of therapy d/t short half life, causing transient hypercoagulable state –> microthrombi, skin necrosis
Hodgkin lymphoma + subtypes
Localized group of nodes Contiguous spread Better prognosis overall than NHL Reed-Sternberg cells (owl eyes) Bimodal (young adults and > 55 yrs); more common in men except NS type EBV-associated
Nodular sclerosing (NS) - most common
Lymphocyte rich - best prognosis
Mixed cellularity - eosinophils, immunocomp
Lymphocyte depleted - immunocomp
Non-Hodgkin lymphoma
Multiple LNs involved & extranodal involvement common
Noncontiguous spread
Mostly B cells involved; few T cell lineage
Adults and children affected
may be HIV/autoimmune-associated
Pyruvate kinase deficiency
AR disorder; results in decreased ATP –> rigid RBCs –> extravascular hemolysis / hemolytic anemia in a newborn
Increases levels of 2,3 BPG to reduce Hb affinity for O2 (release more O2 to tissues)
Pure red cell aplasia
Severe hypoplasia of erythroid marrow elements (causing anemia & low retics), but normal thrombopoiesis & granulopoiesis. Associated w/ thymoma, lymphocytic leukemias, & Parvo B19
Multiple myeloma vs. Waldenstrom macroglobulinemia
MM: Plasma cell cancer (fried egg appearance) arising in BM; produces lots of (mostly) IgG and (some) IgA. CRAB: hyperCa, Renal involvement, Anemia, Bone lytic lesions/Back pain.
WM: M spike (IgM) –> hyperviscosity syndrome (blurred vision, Raynaud’s). No CRAB sx.
ALK
Oncogene; receptor tyr kinase Lung adenocarcinoma ("Adenocarcinoma of the Lung Kinase = ALK")
BCR-ABL
Oncogene; tyrosine kinase
CML, ALL
BCL-2
Oncogene; antiapoptotic molecule
Follicular and DLBC lymphomas
BRAF
Oncogene; serine/threonine kinase (cytoplasmic signal transducer protein)
Melanoma (V600E), NHL, papillary thyroid carcinoma
c-KIT
Oncogene; cytokine receptor
GIST
c-MYC
Oncogene; transcription factor Burkitt lymphoma (t(8;14))
HER2/neu (c-erbB2)
Oncogene; receptor tyrosine kinase
Breast and gastric carcinomas
JAK2
Oncogene; cytoplasmic (non-receptor) tyrosine kinase
Chronic myeloproliferative disorders e.g. polycythemia vera
KRAS
Oncogene; GTPase
Colon, lung, pancreatic cancer
MYCL1
Oncogene; transcription factor
Lung tumor
N-myc (MYCN)
Oncogene; transcription factor
Neuroblastoma
RET
Oncogene; receptor tyr kinase
MEN 2A/2B, papillary thyroid carcinoma